(The Lancet Respiratory Medicine), (ISSN 2213-2600), 刊出呼吸病和重症监护方面的原创研究、评论等。包括但不限于哮喘、COPD、肺癌、重症监护、控烟、肺炎、肺结核、睡眠医学等。
The Lancet Respiratory Medicine launched in March 2013 and is the fourth Lancet specialty journal following in the footsteps of The Lancet Oncology, The Lancet Neurology, and The Lancet Infectious Diseases. The journal offers the same unique fast track experience offered by its sister journals for all authors of research papers that are selected for peer review, where articles can be published online within 8 weeks of submission.
The journal publishes a range of article types in respiratory medicine and critical care. These include Original Research, Reviews, Personal Views, Comments, and News articles. Topics include but are not limited to asthma, COPD, tobacco control, critical care, lung cancer, cystic fibrosis, pneumonia, sarcoidosis, mesothelioma, sleep medicine, thoracic and reconstructive surgery, tuberculosis, palliative medicine, and respiratory infections